Association study between HTR2A rs6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 754, doi. 10.1002/ddr.21686
- By:
- Publication type:
- Article
Works matching IS 02724391 AND DT 2020 AND VI 81 AND IP 6
Results: 14
1
2
Antinociceptive effects of ceftriaxone in formalin‐induced nociception.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 728, doi. 10.1002/ddr.21680
- By:
- Publication type:
- Article
3
Aspartate semialdehyde dehydrogenase inhibition suppresses the growth of the pathogenic fungus Candida albicans.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 736, doi. 10.1002/ddr.21682
- By:
- Publication type:
- Article
4
Monensin inhibits proliferation, migration, and promotes apoptosis of breast cancer cells via downregulating UBA2.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 745, doi. 10.1002/ddr.21683
- By:
- Publication type:
- Article
5
In vitro–in vivo evaluation of tetrahydrozoline‐loaded ocular in situ gels on rabbits for allergic conjunctivitis management.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 716, doi. 10.1002/ddr.21677
- By:
- Publication type:
- Article
6
In vivo pharmacokinetic study and oral glucose tolerance test of sulfoxide analogs of GPR40 agonist TAK‐875.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 708, doi. 10.1002/ddr.21675
- By:
- Publication type:
- Article
7
COVID‐19 transmission through host cell directed network of GPCR.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 647, doi. 10.1002/ddr.21674
- By:
- Publication type:
- Article
8
Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein–ligand recognition process.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 685, doi. 10.1002/ddr.21673
- By:
- Publication type:
- Article
9
Response to recent commentaries regarding the involvement of angiotensin‐converting enzyme 2 (ACE2) and renin‐angiotensin system blockers in SARS‐CoV‐2 infections.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 643, doi. 10.1002/ddr.21672
- By:
- Publication type:
- Article
10
Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 700, doi. 10.1002/ddr.21671
- By:
- Publication type:
- Article
11
Antiurolithiatic effects of pentacyclic triterpenes: The distance traveled from therapeutic aspects.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 671, doi. 10.1002/ddr.21670
- By:
- Publication type:
- Article
12
A comprehensive review of computational techniques for the prediction of drug side effects.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 650, doi. 10.1002/ddr.21669
- By:
- Publication type:
- Article
13
Repurposing therapeutic agents and herbal medicines to defeat viral nemesis.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 641, doi. 10.1002/ddr.21668
- By:
- Publication type:
- Article
14
Issue Information ‐ TOC.
- Published in:
- Drug Development Research, 2020, v. 81, n. 6, p. 639, doi. 10.1002/ddr.21553
- Publication type:
- Article